Help us to keep NOEW free and accessible for our community!Donate
Fran Heller is the founder and CEO of Good2Go, Inc., a startup dedicated to developing technology for everyday needs. Good2Go's first product launch is an innovative system that bridges the physical and digital worlds to grant consumers credentials for immediate access to secure sites and structures. Prior to starting Good2Go, Heller was an executive in the pharmaceutical and biotech industries with expertise in business development, licensing and legal affairs. Most recently, she was senior vice president of business development at Bristol-Myers Squibb and a trustee of the Bristol-Myers Squibb Foundation. She currently serves as a trustee of the Dana Farber Cancer Institute and is a member of the board of directors at Affinivax, a private early stage vaccine company. She is a member of the California State Bar and licensed by the U.S. Patent and Trademark Office. She holds a BS in biology from Tulane University, an MA in biology from American University and a JD from Golden Gate University School of Law.